Mitochondrial Energy System

Investigating the molecular mechanisms that govern cellular energy production, mitochondrial biogenesis, and metabolic adaptation.

System Overview Energy at the Source. Research Into Mitochondrial Biology.

The Mitochondrial Energy System encompasses the molecular networks that govern how cells produce, regulate, and adapt their energy supply. Mitochondria are far more than ATP-generating organelles: they function as dynamic signaling hubs that communicate with the nucleus, regulate apoptosis, modulate oxidative stress, and integrate metabolic signals from the broader cellular environment. Research in this field investigates how disruptions in mitochondrial architecture and bioenergetics relate to aging, metabolic dysfunction, and tissue decline — and, conversely, how specific molecular interventions might influence these processes in controlled experimental models.

  • Ler mais

Core Mechanisms Four Research Axes in Mitochondrial Biology

The compounds in this system are investigated through four primary mechanistic frameworks. Each represents a distinct entry point into mitochondrial function.

NAD+/Sirtuin Axis & Cellular Energy Sensing

NAD+ functions as both a metabolic coenzyme and a signaling substrate. Research investigates how its progressive decline with aging affects the activity of sirtuin deacylases (SIRT1–7), which regulate mitochondrial biogenesis, oxidative stress response, and genomic stability through PGC-1α coactivation and downstream transcriptional programs.

Mitochondrial Membrane Integrity & OXPHOS

The architecture of the inner mitochondrial membrane — shaped by cardiolipin composition and cristae morphology — determines the efficiency of respiratory complex assembly and oxidative phosphorylation. Studies examine how targeted compounds influence this structural framework, ATP synthesis rates, and the cellular response to ischemic or oxidative challenge.

Mitochondrial Biogenesis via ERR/PGC-1α

The estrogen-related receptor (ERR) family, acting in concert with PGC-1α, regulates the transcriptional programs that govern mitochondrial content and oxidative capacity in energy-demanding tissues. Research investigates synthetic ERR agonists as tools to pharmacologically recapitulate exercise-induced adaptive gene expression in preclinical models.

Mitochondria-to-Nucleus Retrograde Signaling

Mitochondrial-derived peptides (MDPs) such as MOTS-c are investigated as endogenous signals that translocate to the nucleus under metabolic stress, modulating gene expression through AMPK activation and antioxidant response element (ARE) pathways — a form of retrograde communication linking mitochondrial status to nuclear transcription.

Related Compounds Research Compounds in This System

Each compound is classified within the Mitochondrial Energy System by its primary mechanism of action. Compounds with broader biological activity are noted accordingly.

MOTS-c
Mitochondrial peptide

Encoded within the mitochondrial genome's 12S rRNA region. Investigated for its role in AMPK activation, retrograde nucleus signaling, and metabolic energy regulation in animal models and in vitro studies.

View Product
NAD+
Coenzyme

Essential coenzyme for oxidative phosphorylation and required substrate for sirtuins. Researched in the context of age-associated decline, mitochondrial biogenesis, and DNA repair pathway regulation.

View Product
SS-31 (Elamipretide)
Synthetic tetrapeptide

Selectively accumulates at the inner mitochondrial membrane via cardiolipin interaction. Investigated across preclinical models and early clinical studies for its influence on respiratory complex function and ATP recovery under conditions of mitochondrial dysfunction. Note: AXION's compound is a research-grade (RUO) version and is not related to, nor a substitute for, any approved pharmaceutical product

View Product
SLU-PP-332
Small molecule — ERR agonist

Synthetic pan-agonist of estrogen-related receptors (ERRα/β/γ). Studied in animal models as a pharmacological tool to activate mitochondrial biogenesis and oxidative transcriptional programs. Primary mechanism: ERRα/γ activation. Metabolic effects are secondary to this primary pathway. Strictly preclinical evidence to date.

View Product
Epithalon
Synthetic tetrapeptide

Derived from pineal gland extract research. Investigated for telomerase activation, telomere extension, and circadian-mitochondrial regulatory axis modulation. Primary literature concentrated in long-term in vitro and animal longevity models. Source concentration in the Khavinson group (St. Petersburg) should be noted when evaluating evidence.

View Product
View individual molecule pages for full mechanism profiles, pathway data, and research status.

Pathways & Biological Context Key Research Pathways

The following molecular pathways represent the primary mechanistic terrain investigated in this system. Individual compounds engage these pathways through distinct mechanisms.

  • NAD+/SIRT1/PGC-1α axis — mitochondrial biogenesis and oxidative stress response
  • AMPK (AMP-activated protein kinase) — central cellular energy sensor
  • ERRα/β/γ (Estrogen-Related Receptors) — upstream transcriptional regulation of mitochondrial biogenesis
  • Folate-AICAR-AMPK pathway — primary signaling axis of MOTS-c retrograde communication
  • NAD+/SIRT1/PGC-1α axis — mitochondrial biogenesis and oxidative stress response
  • AMPK (AMP-activated protein kinase) — central cellular energy sensor
  • ERRα/β/γ (Estrogen-Related Receptors) — upstream transcriptional regulation of mitochondrial biogenesis
  • Folate-AICAR-AMPK pathway — primary signaling axis of MOTS-c retrograde communication

Related Articles - Research Library Explore the Science Behind This System

The Research Library provides in-depth editorial coverage of the mechanisms, evidence, and investigative directions relevant to this system. Each article connects to one or more related compounds in the AXION catalog.

RUO — Research Use Only | Not for Human or Veterinary Use

All compounds listed in this system are classified as Research Use Only (RUO). They are not approved for therapeutic, diagnostic, or clinical use in humans or animals. AXION does not make therapeutic claims of any kind. Access to compounds is available through AXION's structured access model.